Baird analyst Brian Skorney lowered the price target on Voyager Therapeutics (NASDAQ: VYGR) to $27.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Voyager Therapeutics (VYGR) PT Lowered to $13 at Morgan StanleyNovember 8, 2018 8:07 AM Voyager Therapeutics (VYGR) PT Lowered to $18 at WedbushNovember 8, 2018 6:40 AM Voyager Therapeutics (VYGR) Reports Positive Longer-Term Data for VY-AADC for Parkinson’s DiseaseNovember 7, 2018 5:28 PM After-Hours Movers 11/7: (ALAM) (CVNA) (FOSL) Higher; (VYGR) (KRO) (WYNN) Lower (more...)November 7, 2018 5:27 PM Form 10-Q Voyager Therapeutics, For: Sep 30November 7, 2018 4:47 PM Form 8-K Voyager Therapeutics, For: Nov 07November 7, 2018 4:24 PM Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinson’s DiseaseNovember 7, 2018 4:10 PM Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate HighlightsNovember 7, 2018 4:10 PM